[Secondary osteoporosis - relevant clinical characteristics in diagnosis and therapy]

Dtsch Med Wochenschr. 2012 Feb;137(7):326-32. doi: 10.1055/s-0031-1298867. Epub 2012 Feb 8.
[Article in German]

Abstract

Osteoporosis is a systemic skeletal disease causing increased fracture risk. According to pathogenesis, primary (70 - 80 %) and secondary osteoporosis (20 - 30 %) are distinguished. Secondary osteoporosis comprises all entities in which osteoporosis is predominantly and causally associated with certain diseases or conditions. The aim of this review article is to put attention to special features in diagnosis, prophylaxis and treatment of secondary osteoporosis in general and to demonstrate some forms of secondary osteoporosis which seem particularly important during clinical practice. The manuscript refers to the guidelines of the DVO 2009 for prevention, diagnosis and therapy of osteoporosis and selective original papers considering the special types of secondary osteoporosis. History, clinical examination and basic laboratory tests are indicative for the diagnosis of secondary osteoporosis. Its clinical presentation is frequently characterized by rapid development and multiple fractures. Therefore, early diagnosis, prophylaxis and causal treatment is decisive. If causal treatment is impossible, risk adaption of bone mineral density (BMD) for osteoporosis specific treatment is essential. Common causes are medications, endocrine, gastrointestinal and hematologic diseases. Glucocorticoid induced osteoporosis, antihormonal therapy (aromatase inhibitor in women with breast cancer, androgen deprivation therapy in men with prostate cancer) and vitamin D deficiency causing secondary hyperparathyroidism are presented in detail. History and basic laboratory testing are decisive to identify possible causes for secondary osteoporosis and to initiate early diagnostic procedures. The risk of severe osteoporosis can be reduced by early and causal treatment or by risk stratified early bone specific medication if causal therapy is impossible.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Bone Density Conservation Agents / therapeutic use
  • Humans
  • Osteoporosis / chemically induced
  • Osteoporosis / diagnosis*
  • Osteoporosis / physiopathology
  • Osteoporosis / prevention & control
  • Osteoporosis / therapy*
  • Risk Factors

Substances

  • Bone Density Conservation Agents